Boule Diagnostics AB (publ)

OM:BOUL Stok Raporu

Piyasa değeri: SEK 271.8m

Boule Diagnostics Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Boule Diagnostics şirketinin kazançları yıllık ortalama -21.9% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 22.9% oranında artan oldu. Gelirler yıllık ortalama 6.1% oranında artan oldu.

Anahtar bilgiler

-21.9%

Kazanç büyüme oranı

-17.1%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi6.2%
Gelir büyüme oranı6.1%
Özkaynak getirisi-83.4%
Net Marj-37.7%
Sonraki Kazanç Güncellemesi11 Feb 2025

Yakın geçmiş performans güncellemeleri

Recent updates

Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Oct 10
Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jul 25
Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Jul 24
Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Jun 06
Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

May 10
Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Mar 20
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Feb 09
Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Dec 30
Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Jul 25
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

May 26
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Jul 26
Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

Jul 19
Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Mar 06
We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Feb 03
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Apr 29
The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Apr 09
Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Mar 25
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Mar 07
Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

Feb 17
Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Jan 30
These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

Jan 14
Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Dec 28
How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Dec 10
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

Nov 22
What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

Gelir ve Gider Dağılımı

Boule Diagnostics nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

OM:BOUL Gelir, gider ve kazançlar (SEK Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24563-213164310
30 Jun 245732116249
31 Mar 245762715548
31 Dec 235712515353
30 Sep 235721914952
30 Jun 235581714850
31 Mar 235591614653
31 Dec 225481314452
30 Sep 225392713850
30 Jun 225253213148
31 Mar 224952812645
31 Dec 214632312043
30 Sep 21416-2711542
30 Jun 21403-1311342
31 Mar 21383-5510744
31 Dec 20400-4811143
30 Sep 20437-811641
30 Jun 20470-811937
31 Mar 204993513032
31 Dec 194993812830
30 Sep 194763212631
30 Jun 194562112433
31 Mar 194443611533
31 Dec 184244111029
30 Sep 184254811124
30 Jun 184246011225
31 Mar 184214311127
31 Dec 174283711632
30 Sep 174223111438
30 Jun 174212811038
31 Mar 174193810938
31 Dec 163973610537
30 Sep 16383369740
30 Jun 16364229642
31 Mar 16341159342
31 Dec 15331158940
30 Sep 15333299531
30 Jun 15318339126
31 Mar 15309338923
31 Dec 14307308824
30 Sep 14289148324
30 Jun 14285-688325
31 Mar 14287-648424
31 Dec 13277-708424

Kaliteli Kazançlar: BOUL şu anda kârlı değil.

Büyüyen Kar Marjı: BOUL şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: BOUL kârlı değildir ve zararlar son 5 yılda yılda 21.9% oranında artmıştır.

Büyüme Hızlandırma: BOUL 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: BOUL kârlı olmadığından, geçmiş yıl kazanç büyümesinin Medical Equipment sektörüyle ( 31% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: BOUL hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -83.38% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin